Vitrolife AB (OSTO:VITR) Total Liabilities : kr3,640 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Total Liabilities?

Vitrolife AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr3,640 Mil.

Vitrolife AB's quarterly Total Liabilities declined from Sep. 2023 (kr3,749.00 Mil) to Dec. 2023 (kr3,606.00 Mil) but then increased from Dec. 2023 (kr3,606.00 Mil) to Mar. 2024 (kr3,640.00 Mil).

Vitrolife AB's annual Total Liabilities declined from Dec. 2021 (kr4,088.00 Mil) to Dec. 2022 (kr3,811.00 Mil) and declined from Dec. 2022 (kr3,811.00 Mil) to Dec. 2023 (kr3,606.00 Mil).

Vitrolife AB Total Liabilities Historical Data

The historical data trend for Vitrolife AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Total Liabilities Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

341.06

288.08

4,088.00

3,811.00

3,606.00

Vitrolife AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															3,747.00	3,969.00	3,749.00	3,606.00	3,640.00

Vitrolife AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vitrolife AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	557	+	(1942	+	1107
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3,606

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	16329	-	12723
	=	3,606

Vitrolife AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	556	+	(1951	+	1133
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	3,640

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	16873	-	13233
	=	3,640

Vitrolife AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB (OSTO:VITR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

0YAY:UK VTFN:Germany

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB (OSTO:VITR) Headlines

No Headlines